This article is more than 5 years old. Information may no longer be current.

Ista receives subpoena relating to Xibrom promotional practices

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

IRVINE, Calif. — Ista Pharmaceuticals has received a subpoena from the United States Attorney's Office in Buffalo, N.Y., requesting documents regarding promotional, educational and other activities relating to its bromfenac sodium ophthalmic solution Xibrom, the company announced in a press release.

"It is Ista's policy to fully comply with all applicable U.S. and foreign laws, rules and regulations of governmental agencies or other authorities. In particular, the company's code of conduct and legal compliance statutes are intended to ensure full compliance with all laws, rules and regulations governing the sale and marketing of pharmaceutical products," the release said.

Ista plans to fully cooperate in responding to the subpoena, the release said.